CBLL — Ceribell, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1861107 ·
Last close
$25.97
Market Cap
$1.01B
52W High
$28.89
52W Low
$12.65
ADV30
573,215
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 29,341,000 | 26,340,000 | -20,548,000 | -21,351,000 | 156,370,000 | 41,989,000 | 38,833,000 |
| Jun 2026 | 28,097,000 | 25,938,000 | -19,981,000 | -19,268,000 | 166,348,000 | 32,663,000 | 38,035,000 |
| Mar 2026 | 26,494,000 | 23,122,000 | -20,745,000 | -19,737,000 | 178,078,000 | 45,252,000 | 37,265,000 |
| Dec 2025 | 24,784,000 | 21,643,000 | -14,596,000 | -13,527,000 | 195,803,000 | 40,476,000 | 40,467,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-56,012,000
Investing CF
$68,767,000
Financing CF
$5,495,000
CapEx
$-1,474,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.94
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-280,712,000
Inventory
$6,955,000
Receivables
$17,792,000
ST Investments
$75,478,000
EBIT TTM
$-72,282,000
Pretax Income TTM
$-73,883,000
Interest Exp TTM
$1,601,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$108,717,000
EBITDA
$-74,846,000
Free Cash Flow
$-33,006,376
Enterprise Value
$936,805,888
Total Cash
$117,467,000
Total Debt
$21,650,000
Shares Out
38,835,010
Trailing EPS
$-1.95
Book Value
$3.03
ROE
-52.5%
ROA
-26.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 89,063,000 | -58,402,000 | -53,412,000 | 195,803,000 | 40,467,000 | 155,336,000 | -40,808,000 |
| Dec 2024 | 65,444,000 | -39,709,000 | -40,455,000 | 225,412,000 | 34,247,000 | 191,165,000 | -35,043,000 |
| Dec 2023 | 45,225,000 | -30,041,000 | -29,464,000 | 58,922,000 | 171,174,000 | -112,252,000 | -29,159,000 |
| Dec 2022 | 25,922,000 | -36,021,000 | -37,164,000 | 86,458,000 | 172,856,000 | -86,398,000 | -32,002,000 |
TTM Snapshot
Revenues TTM
$101,964,000
NetIncome TTM
$-65,997,000
OpCashFlow TTM
—
Assets (Latest)
$166,348,000
Forward EPS
$-1.71
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $25.63 · call volume: 47 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SIBN | SI-BONE, Inc. | $1.04B | $23.16 | — |
| SGP | SpyGlass Pharma, Inc. | $1.05B | $31.43 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.05B | $13.55 | — |
| ATEC | Alphatec Holdings, Inc. | $1.06B | $6.94 | — |
| IRMD | IRADIMED CORP | $1.07B | $83.45 | — |
News headlines (Yahoo Finance, 1h cache)
CeriBell (CBLL) Climbed, What Is Behind The Fresh Attention?
2026-11-07 21:11 · Yahoo
Ceribell (CBLL) Stock Gets Fair Value Bump As Analysts Back Rapid EEG Growth
2026-11-06 08:14 · Yahoo
How Raised Revenue Guidance At CeriBell (CBLL) Has Changed Its Investment Story
2026-11-05 00:24 · Yahoo
CeriBell (CBLL) Q3 2026 Earnings Call Transcript
2026-11-04 16:47 · Yahoo
CeriBell, Inc. Q3 2026 Earnings Call Summary
2026-11-04 13:30 · Yahoo
CeriBell Inc (CBLL) (Q3 2026) Earnings Call Highlights: Record Hospital Additions and 30% ...
2026-11-04 05:11 · Yahoo
CeriBell Q3 Earnings Call Highlights
2026-11-04 00:14 · Yahoo
CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates
2026-11-03 23:55 · Yahoo
Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics
2026-11-03 23:00 · Yahoo
Ceribell Reports Third Quarter 2026 Financial Results
2026-11-03 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.